(Total Views: 284)
Posted On: 04/16/2019 4:06:00 PM
Post# of 72433
Your point of only one suitor if someone is indeed helping us thru the EMA is so obvious I missed it. Thanks for a slap of reality.
I also missed in the PR that an oral form of K will actually " enhance the therapeutic benefits based on its pharmacokinetics, and broaden its market potential by meeting cancer patient’s strong preference for oral meds."
Just keeps getting better and better.
I also missed in the PR that an oral form of K will actually " enhance the therapeutic benefits based on its pharmacokinetics, and broaden its market potential by meeting cancer patient’s strong preference for oral meds."
Just keeps getting better and better.
(2)
(0)